Literature DB >> 28601660

SMARCA4-deficient thoracic sarcoma: report of a case and insights into how to reach the diagnosis using limited samples and resources.

Satoshi Kuwamoto1, Michiko Matsushita2, Kenichi Takeda3, Natsumi Tanaka3, Yukari Endo4, Akira Yamasaki3, Kenichi Kohashi5, Yoshinao Oda5, Yasushi Horie4.   

Abstract

SMARCA4-deficient thoracic sarcoma is a recently proposed new entity of soft tissue sarcomas with an undifferentiated round cell morphology that is diagnostically challenging. Here we report a case of this tumor where the diagnosis was established using limited samples and resources. A woman in her early 30s developed two intrathoracic masses. Biopsies for these lesions showed sheets of undifferentiated round/rhabdoid cells that retained SMARCB1 expression. Further analysis revealed a reduced SMARCA4 expression and a complete loss of SMARCA2 expression in tumor cells. Subsequent Sanger sequencing identified a nonsense c.1546A>T (p.516Lys>Ter) mutation in SMARCA4 and confirmed the diagnosis. Our case highlighted clinicopathological correlation and rational use of tissue sections for immunohistochemistry may enable to diagnose this tumor even when only limited samples are available. Recognition of this new entity is important for further understanding of the disease and the future development of specific therapies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Immunohistochemistry; Mutation analysis; Rhabdoid cells; SMARCA4-deficient thoracic sarcoma; SWI/SNF complex

Mesh:

Substances:

Year:  2017        PMID: 28601660     DOI: 10.1016/j.humpath.2017.05.024

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

Review 1.  Update on selected advances in the immunohistochemical and molecular genetic analysis of soft tissue tumors.

Authors:  Khin Thway; Andrew L Folpe
Journal:  Virchows Arch       Date:  2019-11-07       Impact factor: 4.064

Review 2.  Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Authors:  Kyriakos Chatzopoulos; Jennifer M Boland
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

3.  Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.

Authors:  Amandine Crombé; Nicolas Alberti; Nicolas Villard; Frank Pilleul; Xavier Buy; François Le Loarer; Michèle Kind
Journal:  Eur Radiol       Date:  2019-02-14       Impact factor: 5.315

4.  Malignant Rhabdoid Tumor of the Mediastinum: A Case Report and Literature Review.

Authors:  Wing Ki Ng; Boon Ping Toe; Hin Yue Lau
Journal:  J Clin Imaging Sci       Date:  2019-03-28

5.  SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.

Authors:  Takahiro Utsumi; Yohei Taniguchi; Yuri Noda; Mari Fukai; Kayoko Kibata; Tomohiro Murakawa
Journal:  Thorac Cancer       Date:  2022-07-02       Impact factor: 3.223

6.  SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas.

Authors:  Natasha Rekhtman; Joseph Montecalvo; Jason C Chang; Deepu Alex; Ryan N Ptashkin; Ni Ai; Jennifer L Sauter; Brie Kezlarian; Achim Jungbluth; Patrice Desmeules; Amanda Beras; Justin A Bishop; Andrew J Plodkowski; Mrinal M Gounder; Adam J Schoenfeld; Azadeh Namakydoust; Bob T Li; Charles M Rudin; Gregory J Riely; David R Jones; Marc Ladanyi; William D Travis
Journal:  J Thorac Oncol       Date:  2019-11-18       Impact factor: 15.609

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.